secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0000950170-24-002543
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema Pharmaceuticals enters $150M ATM equity offering with TD Cowen, terminates prior Oppenheimer ATM
--------------------------------------------------------------------------------

- Enters ATM agreement with Cowen and Company (TD Cowen) to sell up to $150M of common stock at market prices.
- TD Cowen will receive up to 3.0% commission on gross proceeds from any sales under the agreement.
- Terminates prior ATM agreement with Oppenheimer & Co., under which no sales were made.
- No obligation to sell any shares; ATM may be terminated at any time.
- Proceeds expected for general corporate purposes; registration statement effective since May 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000095017024002543/0000950170-24-002543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000095017024002543/olma-20240105.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer